(Q39977027)

16 September 2017

title

Keloid formation after syndactyly release in patients with associated macrodactyly: management with methotrexate therapy (English)

1 reference

16 September 2017

0 references

1 reference

S K Tolerton

1

1 reference

16 September 2017

M A Tonkin

series ordinal

2

1 reference

16 September 2017

publication date

29 March 2011

1 reference

16 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Journal of Hand Surgery

1 reference

16 September 2017

volume

36

1 reference

16 September 2017

issue

6

1 reference

16 September 2017

page(s)

490-497

1 reference

Keloid pathogenesis and treatment

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

Keloid or hypertrophic scar: the controversy: review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

Current progress in keloid research and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

Scar management: prevention and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

Keloids: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

Levels of evidence for the treatment of keloid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

Influence of silicone on abnormal scarring

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

The immunological aspects of keloid tumor formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

Medical and surgical therapies for keloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

p53 and apoptosis alterations in keloids and keloid fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

Elevated vascular endothelial growth factor in keloids: relevance to tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

Treatment of keloids and hypertrophic scars: a meta-analysis and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

The keloid phenomenon: progress toward a solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

Keloids--clinical diagnosis, pathogenesis, and treatment options.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

Emerging new drugs for scar reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

Expression of apoptosis-associated genes by human dermal scar fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

International clinical recommendations on scar management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

Keloid formation after syndactyly reconstruction: associated conditions, prevalence, and preliminary report of a treatment method

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

On the nature of hypertrophic scars and keloids: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

New Therapies for the Management of Keloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

The use of corticosteroids to treat keloids: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

The molecular basis of keloid and hypertrophic scar formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

Antimitotic drug injections and radiotherapy: a review of the effectiveness of treatment for hypertrophic scars and keloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

From scarless fetal wounds to keloids: Molecular studies in wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753193411402146

21 January 2018

Identifiers

DOI

10.1177/1753193411402146

1 reference

release_psuszd2oxfgajcboypxhydyene

16 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/psuszd2oxfgajcboypxhydyene

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference